DrugPatentWatch Database Preview
Hikma Company Profile
What is the competitive landscape for HIKMA, and when can generic versions of HIKMA drugs launch?
HIKMA has one hundred and sixty approved drugs.
There are five US patents protecting HIKMA drugs. There are two tentative approvals on HIKMA drugs.
Summary for Hikma
| US Patents: | 5 |
| Tradenames: | 121 |
| Ingredients: | 114 |
| NDAs: | 160 |
| Patent Litigation for Hikma: | See patent lawsuits for Hikma |
| PTAB Cases with Hikma as petitioner: | See PTAB cases with Hikma as petitioner |
Drugs and US Patents for Hikma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma Intl Pharms | LITHIUM CARBONATE | lithium carbonate | TABLET;ORAL | 078715-001 | Dec 28, 2010 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Hikma Pharms | AMLODIPINE BESYLATE | amlodipine besylate | TABLET;ORAL | 077771-003 | Apr 12, 2011 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Hikma Farmaceutica | ENALAPRILAT | enalaprilat | INJECTABLE;INJECTION | 078687-001 | Dec 23, 2008 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for HIKMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
| ➤ Subscribe | Capsules | 0.6 mg | ➤ Subscribe | 2016-06-10 |
| ➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
